Previous studies have shown that the genetic knockdown of IGF1R expression using shRNA decreased the transwell invasion of neuroblastoma cells such as IMR32 and SH-SY5Y [34]; however, the effect of IGF1R inhibition on RAS- or NF1-altered neuroblastoma cell invasion is unknown. This evidence concerns the gene NF1 and neuroblastoma.